Cresco Labs (CRLBF) Gross Margin (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Gross Margin came in at 49.86% in Q1 2026, up 242.0% YoY from 14.58% in Q1 2025, and down 3.33% on a QoQ basis from 51.58% in Q4 2025.
Cresco Labs (CRLBF) Gross Margin (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Gross Margin data on file, last reported at 49.86% in Q1 2026.
- Quarterly Gross Margin rose 242.0% year-over-year to 49.86% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 50.11% (up 39.0% YoY) and the FY2025 annual result came in at 49.49%, down 83.0% from the prior year.
- Gross Margin slipped to 49.86% in Q1 2026, from 51.58% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 51.97% in Q3 2024 to a low of 43.81% in Q2 2023.
- A 5-year average of 48.83% and a median of 49.86% in 2026 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin plunged 789 bps — and 2024, when it jumped 760 bps.
- Tracing CRLBF's Gross Margin over 5 years: stood at 43.94% in 2022, then gained by 16 bps to 51.08% in 2023, then retreated by 6 bps to 47.77% in 2024, then gained by 8 bps to 51.58% in 2025, then fell by 3 bps to 49.86% in 2026.
- The last three Gross Margin figures came in at 49.86% (Q1 2026), 51.58% (Q4 2025), and 48.12% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cresco Labs | 290.46 Mn | 226.34 Mn | 86.95 Mn | 50.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.86% |
| Dec 31, 2025 | 51.58% |
| Sep 30, 2025 | 48.12% |
| Jun 30, 2025 | 50.88% |
| Mar 31, 2025 | 47.44% |
| Dec 31, 2024 | 47.77% |
| Sep 30, 2024 | 51.97% |
| Jun 30, 2024 | 51.41% |
| Mar 31, 2024 | 50.03% |
| Dec 31, 2023 | 51.08% |
| Sep 30, 2023 | 49.14% |
| Jun 30, 2023 | 43.81% |
| Mar 31, 2023 | 44.22% |
| Dec 31, 2022 | 43.94% |
| Sep 30, 2022 | 47.09% |
| Jun 30, 2022 | 51.70% |
| Mar 31, 2022 | 50.08% |
| Dec 31, 2021 | 50.52% |
| Sep 30, 2021 | 50.27% |
| Jun 30, 2021 | 48.09% |